Cargando…
Construction, purification, and characterization of a chimeric TH1 antagonist
BACKGROUND: TH1 immune response antagonism is a desirable approach to mitigate some autoimmune and inflammatory reactions during the course of several diseases where IL-2 and IFN-γ are two central players. Therefore, the neutralization of both cytokines could provide beneficial effects in patients s...
Autores principales: | Bello-Rivero, Iraldo, Torrez-Ruiz, Yeny, Blanco-Garcés, Elizabeth, Pentón-Rol, Giselle, Fernández-Batista, Osmani, Javier-González, Luís, Gerónimo-Perez, Haydee, López-Saura, Pedro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1481661/ https://www.ncbi.nlm.nih.gov/pubmed/16716222 http://dx.doi.org/10.1186/1472-6750-6-25 |
Ejemplares similares
-
Report on the Symposium “Molecular Mechanisms Involved in Neurodegeneration”
por: Pentón-Rol, Giselle, et al.
Publicado: (2018) -
Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study
por: Anasagasti-Angulo, Lorenzo, et al.
Publicado: (2009) -
C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective
por: Pentón-Rol, Giselle, et al.
Publicado: (2018) -
C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19-induced Damage to the Nervous System
por: Pentón-Rol, Giselle, et al.
Publicado: (2021) -
Development of chimeric and bifunctional antagonists for CLR/RAMP
receptors
por: Chang, Chia Lin, et al.
Publicado: (2019)